SG11202008791UA - Agent for prevention and/or treatment of pseudomonas aeruginosa infection - Google Patents
Agent for prevention and/or treatment of pseudomonas aeruginosa infectionInfo
- Publication number
- SG11202008791UA SG11202008791UA SG11202008791UA SG11202008791UA SG11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA SG 11202008791U A SG11202008791U A SG 11202008791UA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- agent
- treatment
- pseudomonas aeruginosa
- aeruginosa infection
- Prior art date
Links
- 208000032536 Pseudomonas Infections Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018080756 | 2018-04-19 | ||
PCT/JP2019/016441 WO2019203260A1 (en) | 2018-04-19 | 2019-04-17 | Agent for prevention and/or treatment of pseudomonas aeruginosa infection |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202008791UA true SG11202008791UA (en) | 2020-11-27 |
Family
ID=68238941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202008791UA SG11202008791UA (en) | 2018-04-19 | 2019-04-17 | Agent for prevention and/or treatment of pseudomonas aeruginosa infection |
Country Status (9)
Country | Link |
---|---|
US (1) | US12053496B2 (en) |
EP (1) | EP3782631A4 (en) |
JP (1) | JP7296369B2 (en) |
KR (1) | KR102681178B1 (en) |
CN (1) | CN111867607A (en) |
AU (1) | AU2019257028A1 (en) |
CA (1) | CA3096433A1 (en) |
SG (1) | SG11202008791UA (en) |
WO (1) | WO2019203260A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023026957A1 (en) * | 2021-08-27 | 2023-03-02 | ニュートリー株式会社 | Agent for prevention and/or treatment of porphyromonas gingivalis infection |
CN115090225A (en) * | 2022-05-12 | 2022-09-23 | 重庆中科力泰高分子材料股份有限公司 | Novel efficient aldehyde-removing transparent gel and preparation method thereof |
KR20240033466A (en) | 2022-09-05 | 2024-03-12 | 국립부경대학교 산학협력단 | System and method for analyzing atmospheric environments of urban area |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08283166A (en) * | 1995-04-12 | 1996-10-29 | Nichinichi Seiyaku Kk | Prophylactic agent |
JP2002179580A (en) | 2000-12-13 | 2002-06-26 | Zenwa Gu | Medicament containing propolis extract, royal jelly, and killed enterococcus faecalis |
SG93936A1 (en) | 2001-05-21 | 2003-01-21 | Combi Co | Infection-preventing composition, and food or drink containing the same |
JP2003261453A (en) | 2002-03-11 | 2003-09-16 | Nippon Berumu Kk | Antitumor agent and radiation-protecting agent consisting of e. faecalis |
US20090098520A1 (en) * | 2007-10-13 | 2009-04-16 | Aaron Wilson | Dressage flexion and extension training device and method |
CN101938992B (en) * | 2008-02-06 | 2013-07-10 | 东英吉利大学 | Composition and method for assisting swallowing |
CN103502434B (en) | 2011-05-06 | 2016-08-17 | 有机平衡医疗股份公司 | Lactic acid bacteria and the compositions containing this lactic acid bacteria |
CN103751223A (en) * | 2011-10-17 | 2014-04-30 | 陈双露 | Infection-suppressing composition, and food containing the same |
US20190053527A1 (en) * | 2015-09-21 | 2019-02-21 | Institut National De La Recherche, Agronomique (Inra) | Method for preparing a probiotic powder using a two-in-one whey-containing nutrient medium |
JP2018080756A (en) | 2016-11-16 | 2018-05-24 | 日本精工株式会社 | Rolling bearing with seal |
-
2019
- 2019-04-17 WO PCT/JP2019/016441 patent/WO2019203260A1/en unknown
- 2019-04-17 CA CA3096433A patent/CA3096433A1/en active Pending
- 2019-04-17 AU AU2019257028A patent/AU2019257028A1/en not_active Abandoned
- 2019-04-17 JP JP2020514408A patent/JP7296369B2/en active Active
- 2019-04-17 KR KR1020207026681A patent/KR102681178B1/en active Active
- 2019-04-17 EP EP19788978.5A patent/EP3782631A4/en not_active Withdrawn
- 2019-04-17 SG SG11202008791UA patent/SG11202008791UA/en unknown
- 2019-04-17 CN CN201980019148.0A patent/CN111867607A/en active Pending
- 2019-04-17 US US16/980,938 patent/US12053496B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2019257028A1 (en) | 2020-10-01 |
CA3096433A1 (en) | 2019-10-24 |
JPWO2019203260A1 (en) | 2021-04-30 |
WO2019203260A1 (en) | 2019-10-24 |
JP7296369B2 (en) | 2023-06-22 |
EP3782631A1 (en) | 2021-02-24 |
CN111867607A (en) | 2020-10-30 |
EP3782631A4 (en) | 2022-01-05 |
KR20210002461A (en) | 2021-01-08 |
US20200405784A1 (en) | 2020-12-31 |
US12053496B2 (en) | 2024-08-06 |
KR102681178B1 (en) | 2024-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL277473B2 (en) | Treatment and prevention of microbial infections | |
ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
EP3639833A4 (en) | Agent for the prevention or treatment of fat-related diseases and/or inflammation | |
EP3294761A4 (en) | COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF PARE INFECTION. COLI | |
IL272097A (en) | Compounds for the prevention and treatment of medical disorders and uses thereof | |
IL270976A (en) | Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections | |
EP3632431A4 (en) | AGENT FOR THE PREVENTION OR TREATMENT OF CEREBRAL ATROPHY | |
SG11202008791UA (en) | Agent for prevention and/or treatment of pseudomonas aeruginosa infection | |
HUE058250T2 (en) | Medicament for prevention or treatment of rhinovirus infection | |
IL282904A (en) | Therapeutic microbiota for the treatment and/or prevention of dysbiosis | |
ZA202000558B (en) | Prevention and/or treatment of neurodegenerative disease | |
EP4041275A4 (en) | Treatment and prevention of nephrotoxin-induced kidney injuries | |
PT4031117T (en) | Agent for use in treatment or prevention of ophthalmic disorders | |
SG11201809811VA (en) | Compositions and methods for treatment of inflammation or infection of the eye | |
GB201704688D0 (en) | Calcicum based clinical material with antimicrobial properties and method of forming for prevention or treatment of infection | |
EP3789019A4 (en) | Composition for prevention or treatment of skin infection | |
ZA201808182B (en) | Composition comprising at least one enzyme and at least one microbicidal molecule for the prevention or treatment of post-implant infections | |
EP3525771A4 (en) | Prevention and/or treatment of contrast-induced acute kidney injury | |
EP3811958A4 (en) | Composition for the prevention and/or treatment of haemorrhoids | |
SI3737378T1 (en) | Palonosetron eye drops for the treatment or prevention of nausea and vomiting | |
HK40112570A (en) | Prevention and/or treatment of contrast-induced acute kidney injury | |
PT3829535T (en) | Compositions for the prevention and treatment of cutaneous affections | |
EP3967300C0 (en) | Composition for the prevention and treatment of infections and/or inflammations | |
HK40101696A (en) | Treatment and prevention of nephrotoxin-induced kidney injuries | |
GB202210704D0 (en) | Biofilm prevention and treatment |